RE:RE:RE:"impressive, paradigm shifting, photodynamic therapy"If we don't get accelerated approval I think Dr. Uddin's timeline is reasonable.
It all depends on how many patients are treated every month. If we (optimistically) treat 5 patients a month we might be finished all the primary treatments by the end of 2023. It will take another 450 days to do all the evaluations which brings us to April 2025. Another 3 months to compile and submit the data brings us to July 2025. Assuming we have breakthrough designation it could take 60 days to get an FDA response, which brings us to September 2025.
If we only treat 3 patients a month we can add another 9 months to that, which takes us to June 2026.